Mitja Lainscak
Mitja Lainscak is an expert in Cardiology at Splošna bolnišnica Murska Sobota (Slovenia). As of October 2026, ScienceLeadR ranks Mitja Lainscak in the top 1% of experts worldwide for Cachexia and Heart Failure, and in the top 1% of experts in Slovenia for Sarcopenia. Mitja Lainscak has authored 468 publications, the most recent in 2026, and is an investigator in 21 clinical trials, 1 of them ongoing. SLR score: 1,530 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Public Health - Biochemistry - Endocrinology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2003 - 2026
Number : 468
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Gut Microbiota in Heart Failure with Preserved Ejection Fraction: Clinical Phenotyping and Therapeutic Opportunities. PMID 42792863 — genes, heart failure, heart, stress, physiological, heart failure, diastolic, therapeutics, gastrointestinal microbiome, microbiota | Biomedicines | 2026 | 0 |
| Cardiac implantable electronic devices in heart failure: needs, challenges, and real-world implementation. PMID 42678627 — heart failure, heart, arrhythmias, cardiac, cardiac resynchronization therapy, therapeutics | Heart Fail Rev | 2026 | 0 |
| When Normal Is Not Normal: Hemoglobin in Heart Failure Revisited. PMID 42670736 — hemoglobins, heart failure, heart, cardiology | J Am Coll Cardiol | 2026 | 0 |
| 2026 ESC Guidelines for the management of heart failure. PMID 42661420 — heart failure, heart, cardiology | Eur Heart J Top journal | 2026 | 16 |
| General and disease-specific health literacy in patients with heart failure: an outcome analysis. PMID 42489092 — quality of life, heart failure, heart, self care, health literacy, literacy | ESC Heart Fail | 2026 | 0 |
Clinical Studies 21
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A study to test whether vicadrostat (BI 690517) in combination with empagliflozin helps people with heart failure 2023-509706-30-00 — safety, heart failure, heart | Phase 3 | Recruiting | 2024 |
LeadR Networks
Main global connection map